Galie Nazzareno, Guidelines for the diagnosis and treatment of pulmonary hypertension, NICE, European society of cardiology, 2009, pp. 30 (Esc Pocket Guidelines). [Research monograph]
Galiè N; Hoeper MM; Humbert M; Torbicki A; Vachiery JL; Barbera JA; Beghetti M; Corris P; Gaine S; Gibbs JS; Gomez-Sanchez MA; Jondeau G; Klepetko W; Opitz C; Peacock A; Rubin L; Zellweger M; Simonneau G., Guidelines for the diagnosis and treatment of pulmonary hypertension., «EUROPEAN RESPIRATORY JOURNAL», 2009, 34, pp. 1219 - 1263 [Scientific article]
Galie N; Hoeper MM; Humbert M; Torbicki A; Vachiery JL; Barbera JA; Beghetti M; Corris P; Gaine S; Gibbs JS; Gomez-Sanchez MA; Jondeau G; Klepetko W; Opitz C; Peacock A; Rubin L; Zellweger M; Simonneau G., Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)., «EUROPEAN HEART JOURNAL», 2009, 30, pp. 2493 - 2537 [Scientific article]
Oudiz RJ; Galiè N; Olschewski H; Torres F; Frost A; Ghofrani HA; Badesch DB; McGoon MD; McLaughlin VV; Roecker EB; Harrison BC; Despain D; Dufton C; Rubin LJ; ARIES Study Group., Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension., «JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY», 2009, 54, pp. 1971 - 1981 [Scientific article]
.Beghetti M; Haworth SG; Bonnet D; Barst RJ; Acar P; Fraisse A; Ivy DD; Jais X; Schulze-Neick I; Galiè N; Morganti A; Dingemanse J; Kusic-Pajic A; Berger RM., Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2009, 68, pp. 948 - 955 [Scientific article]
Nazzareno Galie, Phospodiesterase type 5 inhibitors, in: Pulmonary Hypertension, New York, INFORMA healthcare, 2009, pp. 350 - 355 [Chapter or essay]
Palazzini M; Manes A; Negro L; Marinelli A; Leci E; Gambetti S; Bachetti C; Beciani E; Conficoni E; Branzi A; Galiè N., Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects, «GIORNALE ITALIANO DI CARDIOLOGIA», 2009, 10, pp. 271 - 300 [Scientific article]
Manes A; Marinelli A; Palazzini M; Negro L; Leci E; Gambetti S; Bachetti C; Beciani E; Conficoni E; Branzi A; Galiè N., Pulmonary arterial hypertension. Part II: Medical and surgical treatment, «GIORNALE ITALIANO DI CARDIOLOGIA», 2009, 10, pp. 366 - 381 [Scientific article]
Galie N; Manes A., Pulmonary Hypertension, in: Cardiovascular Medicine, NEW YORK, Oxford University Press, 2009, pp. 892 - 917 [Chapter or essay]
Grünig E; Weissmann S; Ehlken N; Fijalkowska A; Fischer C; Fourme T; Galié N; Ghofrani A; Harrison RE; Huez S; Humbert M; Janssen B; Kober J; Koehler R; Machado RD; Mereles D; Naeije R; Olschewski H; Provencher S; Reichenberger F; Retailleau K; Rocchi G; Simonneau G; Torbicki A; Trembath R; Seeger W., Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia., «CIRCULATION», 2009, 119, pp. 57 - 1747 [Scientific article]
Galiè N; Brundage BH; Ghofrani HA; Oudiz RJ; Simonneau G; Safdar Z; Shapiro S; White RJ; Chan M; Beardsworth A; Frumkin L; Barst RJ, Tadalafil Therapy for Pulmonary Arterial Hypertension.
On behalf of the Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group., «CIRCULATION», 2009, 119, pp. 2303 - 2894 [Scientific article]
Barst RJ; Gibbs JS; Ghofrani HA; Hoeper MM; McLaughlin VV; Rubin LJ; Sitbon O; Tapson VF;Galiè N., Updated evidence-based treatment algorithm in pulmonary arterial hypertension., «JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY», 2009, 54, pp. s78 - s84 [Scientific article]
Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB, Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial, «ANNALS OF INTERNAL MEDICINE», 2008, 149, pp. 521 - 530 [Scientific article]
Galiè, Nazzareno; Olschewski, Horst; Oudiz, Ronald J.; Torres, Fernando; Frost, Adaani; Ghofrani, Hossein A.; Badesch, David B.; Mcgoon, Michael D.; Mclaughlin, Vallerie V.; Roecker, Ellen B.; Gerber, Michael J.; Dufton, Christopher; Wiens, Brian L.; Rubin, Lewis J., Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2., «CIRCULATION», 2008, 117, pp. 3010 - 3019 [Scientific article]
Galie' N; Alessandra Manes; Naushad Hirani; Robert Naeije., Comparative analysis of clinical trials and evidence-based treatment algorithm for pulmonary arterial hypertension, in: BARST R, Pulmonary Arterial Hypertension, CHICHESTER, John Wiley & Sons, Ltd, 2008, pp. 203 - 216 [Chapter or essay]
